(Q38801394)

English

45 years after the discovery of human polyomaviruses BK and JC: Time to speed up the understanding of associated diseases and treatment approaches

scientific article published on November 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 September 2017

1 reference

Europe PubMed Central

45 years after the discovery of human polyomaviruses BK and JC: Time to speed up the understanding of associated diseases and treatment approaches (English)

1 reference

Europe PubMed Central

6 September 2017

1

object named as

Heidi Barth

1 reference

Europe PubMed Central

6 September 2017

Françoise Stoll-Keller

7

object named as

Françoise Stoll-Keller

1 reference

Europe PubMed Central

6 September 2017

Samira Fafi-Kremer

8

object named as

Samira Fafi-Kremer

1 reference

Europe PubMed Central

6 September 2017

5

object named as

Eric Soulier

1 reference

Europe PubMed Central

6 September 2017

2

object named as

Morgane Solis

1 reference

Europe PubMed Central

6 September 2017

author name string

Quentin Lepiller

3

1 reference

Europe PubMed Central

6 September 2017

Charlotte Sueur

4

1 reference

Europe PubMed Central

6 September 2017

Sophie Caillard

6

1 reference

Europe PubMed Central

6 September 2017

language of work or name

0 references

publication date

1 November 2016

1 reference

Europe PubMed Central

6 September 2017

Critical Reviews in Microbiology

1 reference

Europe PubMed Central

6 September 2017

43

1 reference

Europe PubMed Central

6 September 2017

2

1 reference

Europe PubMed Central

6 September 2017

178-195

1 reference

Europe PubMed Central

6 September 2017

A truncated T antigen expressed from an alternatively spliced BK virus early mRNA.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

A fatal case of JC virus meningitis presenting with hydrocephalus in a human immunodeficiency virus-seronegative patient

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Fatal BK virus pneumonia following stem cell transplantation

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Treatment of progressive multifocal leukoencephalopathy with interleukin 7.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Incidence of progressive multifocal leukoencephalopathy in patients without HIV.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

5-HT2 receptors facilitate JC polyomavirus entry.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Frequency and large T (LT) sequence of JC polyomavirus DNA in oligodendrocytes, astrocytes and granular cells in non-PML brain.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Role of a nuclear localization signal on the minor capsid proteins VP2 and VP3 in BKPyV nuclear entry.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Cidofovir inhibits polyomavirus BK replication in human renal tubular cells downstream of viral early gene expression

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Leflunomide inhibition of BK virus replication in renal tubular epithelial cells

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Malawi polyomavirus is a prevalent human virus that interacts with known tumor suppressors

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Risk of natalizumab-associated progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Antibody responses to recombinant polyomavirus BK large T and VP1 proteins in young kidney transplant patients

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

BK virus antibody titers and intensity of infections after renal transplantation

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Risk factors for BK virus infection in the era of therapeutic drug monitoring

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: baseline results of STRATIFY-1.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

A prospective longitudinal study of BK virus infection in 104 renal transplant recipients

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Identification and characterization of mefloquine efficacy against JC virus in vitro

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

miRNA regulation of BK polyomavirus replication during early infection

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS patients in the current era.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Cerebral demyelination associated with disorders of the reticuloendothelial system.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Cidofovir for BK virus-associated hemorrhagic cystitis: a retrospective study

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Rapid reduction of viruria and stabilization of allograft function by fusidic acid in a renal transplant recipient with JC virus-associated nephropathy

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Human polyomavirus JC (JCV) infection of human B lymphocytes: a possible mechanism for JCV transmigration across the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Serotonin receptor 2A blocker (risperidone) has no effect on human polyomavirus JC infection of primary human fetal glial cells

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Polyomavirus JC infects human brain microvascular endothelial cells independent of serotonin receptor 2A.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Molecular characterization of BK and JC viruses circulating among potential kidney donors in Kuwait.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

BKV and JCV large T antigen-specific CD8+ T cell response in HLA A*0201+ kidney transplant recipients with polyomavirus nephropathy and patients with progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

JC virus in the pathogenesis of colorectal cancer, an etiological agent or another component in a multistep process?

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Molecular genetics of the BK virus

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Chinese strains (Type 7) of JC virus are afro-asiatic in origin but are phylogenetically distinct from the Mongolian and Indian strains (Type 2D) and the Korean and Japanese strains (Type 2A).

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

JC virus-iLOV fluorescent strains enable the detection of early and late viral protein expression

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

BK virus as a cofactor in the etiology of prostate cancer in its early stages

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

A cornucopia of human polyomaviruses

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Cloning of the first human anti-JCPyV/VP1 neutralizing monoclonal antibody: epitope definition and implications in risk stratification of patients under natalizumab therapy

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Detection of JC virus-specific cytotoxic T lymphocytes in healthy individuals.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Infection of vero cells by BK virus is dependent on caveolae

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

The human polyomavirus, JCV, uses serotonin receptors to infect cells

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

BK DNA viral load in plasma: evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

From Stockholm to Malawi: recent developments in studying human polyomaviruses

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

5-HT2a inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old disease

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

JC virus in CD34+ and CD19+ cells in patients with multiple sclerosis treated with natalizumab

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

New human papovavirus (B.K.) isolated from urine after renal transplantation

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Efficacy of recombinant human interleukin 7 in a patient with severe lymphopenia-related progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

JC virus minor capsid proteins Vp2 and Vp3 are essential for virus propagation

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Progressive multifocal leukoencephalopathy: why gray and white matter

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Sirolimus in renal transplantation: analysis of safety and efficacy in a nonprotocol conversion group

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Rearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rate

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Risk factors for hemorrhagic cystitis in pediatric allogeneic hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Identification of BK virus in a patient with acquired immune deficiency syndrome and bilateral atypical retinitis

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

European perspective on human polyomavirus infection, replication and disease in solid organ transplantation

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Progressive multi-focal leukoencephalopathy as a rare lethal complication in untreated sarcoidosis

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Natalizumab-associated progressive multifocal leucoencephalopathy: a practical approach to risk profiling and monitoring

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Broadly neutralizing human monoclonal JC polyomavirus VP1-specific antibodies as candidate therapeutics for progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Early events during BK virus entry and disassembly

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Roles of ATM and ATR-mediated DNA damage responses during lytic BK polyomavirus infection

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

New JC virus (JCV) genotypes from papua new guinea and micronesia (type 8 and type 2E) and evolutionary analysis of 32 complete JCV genomes

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Treatment of polyomavirus infection in kidney transplant recipients: a systematic review.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

The rapid generation of mutation data matrices from protein sequences

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Distribution of JC virus genotypes among Serbian patients infected with HIV and in healthy donors.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

The agnoprotein of polyomaviruses: a multifunctional auxiliary protein

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Levofloxacin for BK virus prophylaxis following kidney transplantation: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Oligosaccharides as receptors for JC virus

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Human glial chimeric mice reveal astrocytic dependence of JC virus infection

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Observations on the use of cidofovir for BK virus infection in renal transplantation

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Treatment of BK virus-associated hemorrhagic cystitis in pediatric hematopoietic stem cell transplant recipients with cidofovir: a single-center experience

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Anti-BK virus mechanisms of sirolimus and leflunomide alone and in combination: toward a new therapy for BK virus infection

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Presymptomatic diagnosis with MRI and adequate treatment ameliorate the outcome after natalizumab-associated progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

BKV and SV40 infection of human kidney tubular epithelial cells in vitro.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Identification of gangliosides GD1b and GT1b as receptors for BK virus

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Harnessing the biology of IL-7 for therapeutic application

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

In situ evidence of JC virus control by CD8+ T cells in PML-IRIS during HIV infection

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Characterization of JC virus in cerebrospinal fluid from HIV-1 infected patients with progressive multifocal leukoencephalopathy: insights into viral pathogenesis and disease prognosis

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Determinants of survival in progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Rearrangement of the JC virus regulatory region sequence in the bone marrow of a patient with rheumatoid arthritis and progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Minichromosome from BK virus as a template for transcription in vitro

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Efficacy and safety of ciprofloxacin for prophylaxis of polyomavirus BK virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Mirtazapine and mefloquine therapy for progressive multifocal leukoencephalopathy in a patient infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

JC virus detection by in situ hybridization in brain tissue from elderly patients

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Everolimus leads to a lower risk of BKV viremia than mycophenolic acid in de novo renal transplantation patients: a single-center experience.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

BK-VP3 as a new target of cellular immunity in BK virus infection

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

A Structure-Guided Mutation in the Major Capsid Protein Retargets BK Polyomavirus

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Structure-Function Analysis of the Human JC Polyomavirus Establishes the LSTc Pentasaccharide as a Functional Receptor Motif

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Interferon beta1-a and selective anti-5HT(2a) receptor antagonists inhibit infection of human glial cells by JC virus

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Cidofovir may be deleterious in BK virus-associated nephropathy

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

BK Polyomavirus Infection and Renourinary Tumorigenesis

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Brincidofovir for polyomavirus-associated nephropathy after allogeneic hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Neutralization serotyping of BK polyomavirus infection in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

BK polyomavirus genotypes represent distinct serotypes with distinct entry tropism

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Treatment of progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

African Origin of Polyomavirus JC and Implications for Prehistoric Human Migrations

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Progressive multifocal leukoencephalopathy: current treatment options and future perspectives

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Detection of JC virus DNA fragments but not proteins in normal brain tissue.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Nuclear entry mechanism of the human polyomavirus JC virus-like particle: role of importins and the nuclear pore complex

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

The decade of polyomavirus BK-associated nephropathy: state of affairs

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Commercially available immunoglobulins contain virus neutralizing antibodies against all major genotypes of polyomavirus BK.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

JC polyomavirus mutants escape antibody-mediated neutralization.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Treatment of BK virus-associated nephropathy with CMX001 after kidney transplantation in a young child

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

The risk of polyomavirus-associated graft nephropathy is increased by a combined suppression of CD8 and CD4 cell-dependent immune effects.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

1-O-hexadecyloxypropyl cidofovir (CMX001) effectively inhibits polyomavirus BK replication in primary human renal tubular epithelial cells

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: a treatment option

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Mammalian target of rapamycin signal inhibitors could play a role in the treatment of BK polyomavirus nephritis in renal allograft recipients.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

The Loss of BKV-specific Immunity From Pretransplantation to Posttransplantation Identifies Kidney Transplant Recipients at Increased Risk of BKV Replication.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

BK polyomavirus-specific cellular immune responses are age-dependent and strongly correlate with phases of virus replication

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Donor origin of BKV replication after kidney transplantation

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Use of cidofovir in progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Evolutionarily conserved function of a viral microRNA.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Intravenous immunoglobulin as rescue therapy for BK virus nephropathy.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Fluoroquinolones inhibit human polyomavirus BK (BKV) replication in primary human kidney cells

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Urine cytology findings of polyomavirus infections

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Donor and recipient BKV-specific IgG antibody and posttransplantation BKV infection: a prospective single-center study

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

The Greater Affinity of JC Polyomavirus Capsid for α2,6-Linked Lactoseries Tetrasaccharide c than for Other Sialylated Glycans Is a Major Determinant of Infectivity

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

JC polyomavirus infection is strongly controlled by human leucocyte antigen class II variants

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Viroporin activity of the JC polyomavirus is regulated by interactions with the adaptor protein complex 3.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

MEGA6: Molecular Evolutionary Genetics Analysis version 6.0

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Immune reconstitution inflammatory syndrome in natalizumab-associated PML.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Leflunomide therapy for polyomavirus-induced allograft nephropathy: efficient BK virus elimination without increased risk of rejection

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

The large tumor antigen: a "Swiss Army knife" protein possessing the functions required for the polyomavirus life cycle.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Novel approach for improved assessment of phenotypic and functional characteristics of BKV-specific T-cell immunity.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

The risk of polyomavirus BK-associated hemorrhagic cystitis after allogeneic hematopoietic SCT is associated with myeloablative conditioning, CMV viremia and severe acute GVHD.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Phenotypic and functional characterization of circulating polyomavirus BK VP1-specific CD8+ T cells in healthy adults.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

JC virus quasispecies analysis reveals a complex viral population underlying progressive multifocal leukoencephalopathy and supports viral dissemination via the hematogenous route.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Viral DNA replication-dependent DNA damage response activation during BK polyomavirus infection

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Progressive multifocal leukoencephalopathy following heightened immunosuppression after lung transplant

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Leflunomide for polyomavirus type BK nephropathy

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Epigenetic regulation of polyomavirus JC.

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Effective treatment of severe BK virus-associated hemorrhagic cystitis with leflunomide in children after hematopoietic stem cell transplantation: a pilot study

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Molecular epidemiology of JCV genotypes in patients and healthy subjects from Northern Italy

1 reference

https://api.crossref.org/works/10.1080%2F1040841X.2016.1189873

21 January 2018

Identifiers

10.1080/1040841X.2016.1189873

1 reference

Europe PubMed Central

6 September 2017

1 reference

Europe PubMed Central

6 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38801394&oldid=1787766285"